Methods: We analyzed humoral auto- and alloimmune responses to the non-HLA antigen glutathione S-transferase theta 1 (GSTT1), along with development of de novo ( dn )HLA-DSAs, in a cohort of 146 pediatric non-sensitized recipients of first kidney allograft, to analyze its role in ABMR and graft loss
Oral supplements sit in a near-unregulated zone where manufacturers self-certify compliance and the FDA reacts only when something goes wronga contamination event, a serious adverse reaction, or a company making disease claims so egregious they can't be ignored
Clinics (Sao Paulo, Brazil) 2022;77:100001
This product is sold exclusively for research and educational purposes
Periodic treatment breaks are commonly recommended to prevent receptor adaptation and ensure continued responsiveness
Patients should set expectations accordingly